Literature DB >> 9282942

Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species.

S B Berman1, T G Hastings.   

Abstract

Dopamine can form reactive oxygen species and other reactive metabolites that can modify proteins and other cellular constituents. In this study, we tested the effect of dopamine oxidation products, other generators of reactive oxygen species, and a sulfhydryl modifier on the function of glutamate transporter proteins. We also compared any effects with those on the dopamine transporter, a protein whose function we had previously shown to be inhibited by dopamine oxidation. Preincubation with the generators of reactive oxygen species, ascorbate (0.85 mM) or xanthine (500 microM) plus xanthine oxidase (25 mU/ml), inhibited the uptake of [3H]glutamate (10 microM) into rat striatal synaptosomes (-54 and -74%, respectively). The sulfhydryl-modifying agent N-ethylmaleimide (50-500 microM) also led to a dose-dependent inhibition of [3H]glutamate uptake. Preincubation with dopamine (100 microM) under oxidizing conditions inhibited [3H]glutamate uptake by 25%. Exposure of synaptosomes to increasing amounts of dopamine quinone by enzymatically oxidizing dopamine with tyrosinase (2-50 U/ml) further inhibited [3H]glutamate uptake, an effect prevented by the addition of glutathione. The effects of free radical generators and dopamine oxidation on [3H]glutamate uptake were similar to the effects on [3H]dopamine uptake (250 nM). Our findings suggest that reactive oxygen species and dopamine oxidation products can modify glutamate transport function, which may have implications for neurodegenerative processes such as ischemia, methamphetamine-induced toxicity, and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9282942     DOI: 10.1046/j.1471-4159.1997.69031185.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.

Authors:  Judy P Q Zhu; Wenjing Xu; Jesus A Angulo
Journal:  Brain Res       Date:  2005-07-12       Impact factor: 3.252

2.  Cholesterol depletion from the plasma membrane impairs proton and glutamate storage in synaptic vesicles of nerve terminals.

Authors:  Alla S Tarasenko; Roman V Sivko; Natalia V Krisanova; Nina H Himmelreich; Tatiana A Borisova
Journal:  J Mol Neurosci       Date:  2010-04-06       Impact factor: 3.444

3.  Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress.

Authors:  R Sah; R D Schwartz-Bloom
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

4.  Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

5.  Amphetamine increases extracellular concentrations of glutamate in the prefrontal cortex of the awake rat: a microdialysis study.

Authors:  A Del Arco; R Martínez; F Mora
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

6.  Toxicity of dopamine and dopaminochrome on cultured cells.

Authors:  L Galzigna; L Zanatta; N Esposito
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

7.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

8.  Ascorbic acid attenuates scopolamine-induced spatial learning deficits in the water maze.

Authors:  F E Harrison; A H Hosseini; S M Dawes; S Weaver; J M May
Journal:  Behav Brain Res       Date:  2009-08-22       Impact factor: 3.332

9.  Parkinson's disease: genetics and beyond.

Authors:  N N Inamdar; D K Arulmozhi; A Tandon; S L Bodhankar
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

10.  The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion.

Authors:  John Smythies; Angela De Iuliis; Lucia Zanatta; Lauro Galzigna
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.